← SynDRA
THIAMYLAL
SynDRA canonical compound SYN0000153 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · OTC |
| Primary target(s) | GABRA1 |
| Mechanism of action | Glutamate receptor antagonist |
| Indication | sedative |
| Disease area | neurology/psychiatry |
All known targets
- GABRA1
- GABRG3
- GABRA2
- GABRA3
- GABRA4
- GABRA5
- GABRA6
- GABRB1
- GABRB2
- GABRB3
- GABRD
- GABRE
Mechanisms of action (all sources)
- Glutamate receptor antagonist
- GABRA1 POSITIVE ALLOSTERIC MODULATOR
- GABRB2 POSITIVE ALLOSTERIC MODULATOR
- GABRG2 POSITIVE ALLOSTERIC MODULATOR
- GABRB3 POSITIVE ALLOSTERIC MODULATOR
- GABRA4 POSITIVE ALLOSTERIC MODULATOR
- GABRG3 POSITIVE ALLOSTERIC MODULATOR
- GABRQ POSITIVE ALLOSTERIC MODULATOR
- GABRA3 POSITIVE ALLOSTERIC MODULATOR
- GABRP POSITIVE ALLOSTERIC MODULATOR
- GABRD POSITIVE ALLOSTERIC MODULATOR
- GABRG1 POSITIVE ALLOSTERIC MODULATOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- NR1I2
- CYP3A4
- SLCO1B1
- SLCO1B3
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Anesthetics
- Anesthetics, Intravenous
- Central Nervous System Agents
- Central Nervous System Depressants
- GABA Agents
- GABA Modulators
- Hypnotics and Sedatives
- Neurotransmitter Agents
Cross-references
Synonyms
- SURITAL
- thiamylal sodium
- thioseconal
- thioquinalbarbitone
- NSC-120815
- Surital
- Thioquinalbarbitone
- Thioseconal
- Thiamylal [USAN]
- Surital (TN)
- NSC 120815
- CHEBI:9536
- RefChem:189257
- DTXCID9028415
- Thiamylal [USP]
- EINECS 201-018-3
- UNII-01T23W89FR
- Spectrum_001812
- THIAMYLAL [MI]
- Spectrum2_000384
- Spectrum3_001782
- Spectrum4_000577
- Spectrum5_001901
- THIAMYLAL [VANDF]
- THIAMYLAL [WHO-DD]
- BSPBio_003303
- KBioGR_001014
- KBioSS_002307
- DivK1c_000990
- SCHEMBL548050
- Thiamylal, analytical standard
- SPBio_000567
- GTPL7305
- SCHEMBL12998413
- KBio1_000990
- KBio2_002305
- KBio2_004873
- KBio2_007441
Look up THIAMYLAL in the interactive SynDRA portal →